NORTHWEST BIOTHERAPEUTICS INC (17) | Business Finance (8)

Browse by Subcategory

Loan Agreements (7 contracts)
Note Agreements (1)

Recent Contracts

Loan Agreement, dated September 26, 2022, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on February 28, 2023)
Promissory Note in the principal amount of $1,388,888.89, dated as of May 1, 2018, by and between Northwest Biotherapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 2, 2019)
Loan Agreement, dated November 22, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 1, 2022)
Note and Loan Agreement, dated August 14, 2021, by and between Northwest Biotherapeutics, Inc. and Iliad Research and Trading L.P (Filed With SEC on March 31, 2021)
Loan Agreement, dated March 1, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 31, 2021)
Note and Loan Agreement, dated as of March 14, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)
Note and Loan Agreement, dated as of March 19, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)
Form of Loan Agreement, dated as of November 7, 2018, by and between Northwest Biotherapeutics, Inc. and a Group of Private Lenders (Filed With SEC on April 2, 2019)